Details

NameSymbolSector
MEDICAMEN BIOTECH LTD.MEDICAMEQPharmaceuticals
Open
297
High
299
Low
280.15
Close
284.45
Volume
24971
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

0.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Medicamen Biotech is  
Long Body
Estimated Stoploss of Medicamen Biotech is ₹  
299
Medicamen Biotech has a  
Bearishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates Medicamen Biotech has chances of  
Continuationℹ
 of the current trend. 

Trend

Medicamen Biotech is in  
Downtrendℹ
. 
Price of Medicamen Biotech is  
Upℹ
 by  

0.88

%. 
Target
Buy @ 

235.2

Sell @ 

316.7

Current @ 

284.45

Volume

The trade volumes of Medicamen Biotech have become  
Deficientℹ
Though the volume trend for Medicamen Biotech appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Medicamen Biotech is  

Down

 by  

32.22

% 

Valuation

The current market price of Medicamen Biotech is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 297cr and total assets worth ₹ 297cr, the balance sheet of Medicamen Biotech is:  
Balancedℹ
. 
Cashflow
Medicamen Biotech has  
Badℹ
 cash flow because there is  

Shortage

 of  

₹ 11cr

. It is  
Downℹ
 by  

120

%. 

(*Mar 2025)

80% i.e. ₹ 8cr spent in operatingℹ
10% i.e. ₹ 1cr spent in investingℹ
10% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Medicamen Biotech has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 5cr

. It is  
Downℹ
 by  

131.25

%. 

(*Mar 2024)

35.29% i.e. ₹ 6cr spent in operatingℹ
29.41% i.e. ₹ 5cr spent in investingℹ
35.29% i.e. ₹ 6cr earned in financingℹ
0% in otherℹ
Income
The income of Medicamen Biotech is  

₹ 47cr

 and  

Profit

 is :  

₹ 2cr

(*Sep 2025)

Medicamen Biotech Profit is up by:  

100

% and Income is Up by:  

9.3

% 

(*Sep 2025)

The income of Medicamen Biotech is  

₹ 43cr

 and  

Profit

 is :  

₹ 1cr

(*Jun 2025)

Medicamen Biotech Profit is up by:  

0

% and Income is Up by:  

26.47

% 

(*Jun 2025)

The income of Medicamen Biotech is  

₹ 34cr

 and  

Profit

 is :  

₹ 1cr

(*Mar 2025)

Medicamen Biotech Profit is down by:  

50

% and Income is Down by:  

24.44

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.